Trial reportHealth and quality of life outcomes2014
Impact of a pharmaceutical care programme on health-related quality of life among women with epilepsy: a randomised controlled trial (IPHIWWE study).
Trial report in Health and quality of life outcomes, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Pharmacist services for non-hospitalised patients.The Cochrane database of systematic reviews · 2018Pooled it
- A systematic review and narrative synthesis of group self-management interventions for adults with epilepsy.BMC neurology · 2017Pooled it
- Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital.PloS one · 2019Trial
- Trial
- Implementation fidelity of a self-management course for epilepsy: method and assessment.BMC medical research methodology · 2017Trial
- People with epilepsy obtain added value from education in groups: results of a qualitative study.European journal of neurology · 2017Trial
- Examining Psychological Group Interventions for Adult Epilepsy Patients: A Systematic Review.Noro psikiyatri arsivi · 2025Review
- Global Advancement in Pharmacy Services for Mental Health: A Review for Evidence-Based Practices.Healthcare (Basel, Switzerland) · 2023Review
- Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders.The mental health clinician · 2020Article
- Current Perceptions and Improvement Approaches of Pharmaceutical Care Capacity of Community Pharmacists: A Quantitative Analysis Based on Survey Data at Chinese Chain Pharmacies.International journal of environmental research and public health · 2020Article
- Medication-Related Needs and Humanistic Impact of Patient-Centered Pharmaceutical Care at University of Gondar Comprehensive Specialized Hospital, North-West Ethiopia.Integrated pharmacy research & practice · 2020Article
- How to Improve Clinical Outcome of Epileptic Seizure Control Based on Medication Adherence? A Literature Review.Open access Macedonian journal of medical sciences · 2018Review
- Characteristics associated with quality of life among people with drug-resistant epilepsy.Journal of neurology · 2017Article
- Patients' perception of pharmaceutical services available in a community pharmacy among patients living in a rural area of the United Kingdom.Pharmacy practiceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEpilepsy is a complex chronic disorder which affects health-related quality of life (HRQOL), especially in women.
methodsThis study is a pragmatic randomised controlled trial involving women with epilepsy (WWE) over 18 years of age.
resultsOne hundred eighty-two WWE entered the study and 144 (79.1%) completed it. The t-test for comparing the final QOLIE-31 scores between groups yielded a t = -2.166 and confidence interval (CI) (95%): -10.125; -0.4625, p-value =0.0319. The change (Δ) in the QOLIE-31 score for the IG was 12.45 points (p-value <0.001) and for the control group it was 2.61 (p-value =0.072). With 10.7 as the minimally important change we found a relative risk of 2.17 (CI: 1.37; 3.43) and a number needed to treat (NNT) of 3.5.
conclusionsThe study demonstrated that the application of a pharmaceutical care programme significantly improves HRQOL in WWE. The NNT we found allows a recommendation to implement the PC programme for the additional benefit that would be obtained in patients' HRQOL.
trial registrationCurrent Controlled Trials ISRCTN46864306 IPHIWWE study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.